(Q34654747)

3 August 2017

title

Repeated S-ketamine infusions in therapy resistant depression: a case series (English)

1 reference

3 August 2017

6

Oliver Pogarell

1 reference

3 August 2017

7

Hans-Jürgen Möller

1 reference

3 August 2017

Felix Segmiller

1

1 reference

3 August 2017

Tobias Rüther

2

1 reference

3 August 2017

Andrea Linhardt

3

1 reference

3 August 2017

Frank Padberg

4

1 reference

3 August 2017

Michael Berger

5

1 reference

3 August 2017

Christina Kohler

8

1 reference

3 August 2017

Cornelius Schüle

9

1 reference

3 August 2017

publication date

24 July 2013

1 reference

The Journal of Clinical Pharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

53

1 reference

3 August 2017

issue

9

1 reference

3 August 2017

page(s)

996-998

1 reference

Antidepressant effects of ketamine in depressed patients

3 August 2017

cites work

1 reference

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

Ketamine for depression: where do we go from here?

21 January 2018

1 reference

Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases

21 January 2018

1 reference

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

21 January 2018

1 reference

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

21 January 2018

1 reference

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

21 January 2018

1 reference

Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCPH.122

1 reference

3 August 2017

1 reference